NEW YORK, Oct. 7 (GenomeWeb News) - NuGen Technologies of San Carlos, Calif., said today that it has received a Phase I grant from the NIH to develop its nucleic acid amplification and detection technologies.
The company markets an Ovation RNA amplification system for gene expression, using its singler primer isothermal amplification (SPIA) technology, "a novel means of isothermal linear gene amplification," according to the grant abstract. This technology is incorporated into the company's Ribo-Spia method for isothermal linear RNA amplification, for which it has filed a patent application.
These technologies are designed to be sensitive enough to amplify up samples for small numbers of cells or single cells from tissue biopsies, laser capture microdissection, and other methods of tissue procurement. The company said it plans to use the grant to validate its technologies for this small-sample amplification.
The company did not disclose the amount of the grant, but typical SBIR Phase 1 grants are in the realm of $100,000.